Co-mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancer

Journal of Cellular and Molecular Medicine
Puyuan XingYuankai Shi

Abstract

Osimertinib is designed to target the secondary resistant EGFR T790M mutant and has shown outstanding clinical efficacy. However, the prognostic prediction of osimertinib patients is a big problem in clinical practice. The resistance mechanism of osimertinib is also not fully understood. NGS and a 1021 gene capture panel were used to analyse the somatic mutation profile of thirty-six lung adenocarcinoma patients' serial ctDNA samples. Progression-free survival of subgroup patients is analysed. Patients harbour TP53 mutations and patients with higher TMB value in pre-treatment samples showed a shorter PFS. Moreover, compared to CT evaluation, ctDNA changes generally correlated with treatment responses in most patients. Novel resistance mechanisms are discovered including EGFR mutations and alternative activation pathway. Our results implied a broad potential of ctDNA as an adjuvant tool in practical clinical management of NSCLC patients. ctDNA could help with clinical practice during osimertinib treatment, regarding monitoring tumour response, detecting development of heterogeneity, identifying potential resistance mechanisms, predicting treatment efficacy and patient outcome.

References

Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Mar 15, 2013·The New England Journal of Medicine·Sarah-Jane DawsonNitzan Rosenfeld
Mar 19, 2014·Nature Methods·Andrew RothSohrab P Shah
Apr 30, 2015·The New England Journal of Medicine·Pasi A JänneMalcolm Ranson
Aug 28, 2015·Science Translational Medicine·Isaac Garcia-MurillasNicholas C Turner
Nov 3, 2015·Journal of Structural Biology·Yuliana YosaatmadjaChristopher J Squire
Jun 4, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Melissa BersanelliMarcello Tiseo
Jun 30, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Geoffrey R OxnardPasi A Jänne
Nov 1, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Matteo CanalePaola Ulivi
Dec 14, 2016·The New England Journal of Medicine·Tony S MokUNKNOWN AURA3 Investigators
Dec 23, 2016·Expert Opinion on Therapeutic Targets·Nicola NormannoAntonella De Luca
Jan 18, 2017·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Kai ChenCaicun Zhou
Jan 21, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J RemonB Besse
Mar 14, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Paul A VanderLaanDaniel B Costa
Apr 27, 2017·Nature·Christopher AbboshCharles Swanton
May 26, 2017·International Journal of Cancer. Journal International Du Cancer·Zhi-Xiong CaiJing-Feng Liu
Aug 26, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Catherine LabbéFrances A Shepherd
Aug 26, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·A OztanL E Raez
Oct 4, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yulian KhagiRazelle Kurzrock
Nov 8, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Choong-Kun LeeByoung Chul Cho
Nov 9, 2017·Translational Lung Cancer Research·Lynette Sholl
Dec 9, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dara L AisnerUNKNOWN LCMC2 investigators
Dec 21, 2017·The New England Journal of Medicine·Mark YarchoanElizabeth M Jaffee
Mar 3, 2018·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ryo AriyasuRyohei Katayama
Mar 7, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhe YangCaicun Zhou

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
genotyping

Software Mentioned

PyClone
SPSS
GraphPad Prism
MuTect2
Geneplus
BWA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Sandrine ThéoleyreMarc G Denis
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Audrey ValléeMarc G Denis
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Kai ChenCaicun Zhou
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
G M O'KaneN B Leighl
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Hugo GortaisLuc Cabel
© 2021 Meta ULC. All rights reserved